Augmenting the ubiquitination levels of PTEN promoted NSCLC cell growth, whereas miR-652-3p inhibition promoted the tumor-suppressing effects of the OTUD5/PTEN axis in NSCLC. This evidence concerns the gene OTUD5 and neoplasm.